Intelligent Asthma Monitoring Devices Market Updates

Global Intelligent Asthma Monitoring Devices Market size was valued at USD 645.96 million in 2023 and is poised to grow from USD 811.33 million in 2024 to USD 5024.73 million by 2032, growing at a CAGR of 25.6% during the forecast period (2025-2032). 

Global intelligent asthma monitoring device market is highly fragmented. The players adopted the key strategies to strengthen their position in the global market which is as follows- product launches, mergers & acquisitions, joint venture, and geographical expansion. 'Adherium Limited (New Zealand) ', 'AstraZeneca plc (United Kingdom) ', 'Boehringer Ingelheim International GmbH (Germany) ', 'Cohero Health, Inc. (United States) ', 'GlaxoSmithKline plc (United Kingdom) ', 'Health Care Originals, Inc. (United States) ', 'Koninklijke Philips N.V. (Netherlands) ', 'Teva Pharmaceutical Industries Ltd. (Israel) ', 'Vectura Group plc (United Kingdom) ', 'Volansys Technologies Pvt. Ltd. (India) ', '3M (United States) ', 'AEvice Health (Singapore) ', 'Respiri Limited (Australia) ', 'Quvium (United States) ', 'FindAir (Poland) ', 'Sensirion AG (Switzerland) ', 'Thorasys Thoracic Medical Systems Inc. (Canada) ', 'Vitalograph Ltd. (Ireland) ', 'Zephyr Sleep Technologies (Canada) '

Increasing pollution across the globe is the major factor that contributes to the increasing number of people suffering from asthma. This condition helps to boost sales of intelligent asthma monitoring devices. According to the Centers for Disease Control and Prevention (CDC), over 27 million people in the U.S. suffered from asthma. It was one of the chronic conditions in children, with a prevalence of 1 in every 12 children. According to Asthma UK, there are over 300 million people suffering from asthma and the number is anticipated to rise by over 100 million by 2025. People’s awareness about the advantages of asthma monitoring devices, technological advancement, and increasing company focus are the factors that help to propel the market growth. Smart inhalers include a dry powdered inhaler and metered dose inhaler. Key players are embracing the use of these smart inhalers in order to enhance the management of asthma and also to improve the effectiveness of the prescribed medications that helps to boost the market growth.

ADAMM smart patch is one of the wearables that is used to monitor symptoms like cough, respiration rate, and presence of wheeze. This device is deviate from the individnormsnorm, the wearable vibrates to indicate the user of the deviation and it sends a text notification to a designated person.

Global intelligent asthma monitoring devices market can be segmented into five major regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.